Manas AI · Seed

AI-driven discovery of novel cancer medicines

Amount

$24.6M

Round

Seed

Valuation

—

Announced

Jan 2025

Investors

Lead investor

General Catalyst

Participating investors

Greylock Partners Reid Hoffman